SCHEMBL18909455

SCHEMBL18909455

CCC(=O)N1CCC(CN2CCN(C(=O)OC)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.43
CACNA2D1 P54289 1/20 0.42
CACNA1B Q00975 1/20 0.42
CACNB1 Q02641 1/20 0.42
CACNA1C Q13936 1/20 0.42
EPHX2 P34913 3/20 0.42
HTR4 Q13639 3/20 0.41
CHRM4 P08173 1/20 0.41
BRD4 O60885 1/20 0.40
EPHX1 P07099 1/20 0.40
DRD3 P35462 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.39
THRB P10828 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22891213 0.89 EPHX1 (0.43) PKMCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL21280800 0.87 PKM (0.42) PKMCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL18909445 0.85 CACNA2D1 (0.42) PKMCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL22030872 0.85 CNR1 (0.41) PKMCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL22891191 0.85 KDM4E (0.54) PKMCACNA2D1CACNA1BCACNB1CACNA1C
SCHEMBL20471042 0.84 HRH3 (0.48) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL19013629 0.83 CACNA2D1 (0.51) CACNA2D1CACNA1BCACNB1CACNA1CHTR4
SCHEMBL18909449 0.83 CACNA2D1 (0.45) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2
SCHEMBL13472660 0.82 ALDH1A1 (0.50) EPHX2DRD3POLBMAPT
SCHEMBL24521471 0.82 HSD11B1 (0.47) CACNA2D1CACNA1BCACNB1CACNA1CEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3596072-B1 PYRAZOLOCHLOROPHENYL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-06-22 EP disclosed
EP-3416967-B1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF HOFFMANN LA ROCHE (CH) 2022-02-09 EP disclosed
EP-3380474-B1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF HOFFMANN LA ROCHE (CH) 2019-08-21 EP disclosed
WO-2017140825-A1 THERAPEUTIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-08-24 WO disclosed
WO-2017089390-A1 JANUS KINASES INHIBITORS, COMPOSITIONS THEREOF AND USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2017-06-01 WO disclosed